Letter, dated May 16, 2021, from the Registrant to Neil Josephson
EX-10.2 3 zyme-20210630xex102.htm EX-10.2 Document
May 16, 2021 Exhibit 10.2
Zymeworks Biopharmaceuticals Inc.
Re: Interim Chief Medical Officer
On behalf of the senior leadership team and the Board of Directors, I am pleased to confirm your position as Interim Chief Medical Officer. Your acceptance of this assignment will Include the following changes to your compensation package, effective May 16, 2021.
Your base compensation will remain the same as you take on this interim assignment.
(payable May 31, 2021)
Annual bonus target
Additional Interim Bonus Target
(payable in March 2022)
Additional Stock Option Grant
(granted May 6, 2021)
This is well deserved! I want to personally thank you for all your contributions and commitment to Zymeworks’ success. It is appreciated.
/s/ Kathy O’Driscoll
Chief People Officer
Zymeworks Inc. 540-1385 West 8th Ave, Vancouver, BC, Canada, V6H 3V9 www.zymeworks.com